CITIUS ONCOLOGY, INC.

Nasdaq:CTOR

Pharmaceutical Preparations·CRANFORD, NJ

CEO

Mazur Leonard L

CFO

Bartushak Jaime

Financials

15 shown

Type	Period	Ended	Filed
10-Q	Q4 2025	12/31/25	2/13/26	→
10-K	FY 2025	9/30/25	12/23/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-Q	Q4 2024	12/31/24	2/14/25	→
10-K/A	FY 2024	9/30/24	1/27/25	→
↓

Earnings Releases (8-K)

5 shown

Filed	Period
2/13/26	Q2 FY2026	→
12/23/25	Q1 FY2026	→
8/12/25	Q4 FY2025	→
5/14/25	Q3 FY2025	→
12/27/24	Q1 FY2025	→

News (8-K)

36 shown

Filed	Type	Description
3/4/26	Other	Other Events	→
12/10/25	Agreement	Entry into a Material Definitive Agreement	→
12/1/25	Reg FD	Regulation FD Disclosure	→
10/27/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/23/25	Reg FD	Regulation FD Disclosure	→
9/19/25	Exec Change	Unregistered Sales of Equity Securities	→
↓

Prospectuses & Registrations

27 shown

Filed	Form	Description
1/5/26	S-3	REGISTRATION STATEMENT	→
12/10/25	424B5	PROSPECTUS SUPPLEMENT	→
9/19/25	S-8	REGISTRATION STATEMENT	→
9/10/25	424B3	424B3	→
9/10/25	424B5	PROSPECTUS SUPPLEMENT	→
9/2/25	S-3	REGISTRATION STATEMENT	→
↓

Filing History(232 filings)

TypeDateAccessionPeriodSize

8-K

Mar 4, 2026

0001213900-26-023440CURRENT REPORT

Mar 4, 2026

276.9 KB

EFFECT

Mar 2, 2026

9999999995-26-000698

—

1.8 KB

POS AM

Feb 20, 2026

0001213900-26-018829POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1

—

6.7 MB

SCHEDULE 13G/A

Feb 17, 2026

0001172661-26-001261

—

10.4 KB

8-K

Feb 13, 2026

0001213900-26-015894CURRENT REPORT

Feb 13, 2026

295.1 KB

10-Q

Feb 13, 2026

0001213900-26-015877QUARTERLY REPORT

Dec 31, 2025

3.7 MB

DEF 14C

Jan 29, 2026

0001213900-26-009524DEFINITIVE INFORMATION STATEMENT

Jan 29, 2026

106.3 KB

PRE 14C

Jan 20, 2026

0001213900-26-005689PRELIMINARY INFORMATION STATEMENT

Jan 20, 2026

108.1 KB

EFFECT

Jan 12, 2026

9999999995-26-000150

—

1.8 KB

S-3

Jan 5, 2026

0001213900-26-001187REGISTRATION STATEMENT

—

372.4 KB

8-K

Dec 23, 2025

0001213900-25-125418CURRENT REPORT

Dec 23, 2025

289.8 KB

10-K

Dec 23, 2025

0001213900-25-125331ANNUAL REPORT

Sep 30, 2025

4.6 MB

4/A

Dec 22, 2025

0001213900-25-124537OWNERSHIP DOCUMENT

Sep 19, 2025

5.1 KB

4/A

Dec 22, 2025

0001213900-25-124536OWNERSHIP DOCUMENT

Sep 19, 2025

5.1 KB

4/A

Dec 22, 2025

0001213900-25-124534OWNERSHIP DOCUMENT

Sep 19, 2025

5.2 KB

4/A

Dec 22, 2025

0001213900-25-124535OWNERSHIP DOCUMENT

Sep 19, 2025

5.2 KB

4/A

Dec 22, 2025

0001213900-25-124533OWNERSHIP DOCUMENT

Sep 19, 2025

5.2 KB

4/A

Dec 22, 2025

0001213900-25-124532OWNERSHIP DOCUMENT

Sep 19, 2025

5.1 KB

4/A

Dec 22, 2025

0001213900-25-124531OWNERSHIP DOCUMENT

Sep 19, 2025

5.1 KB

4/A

Dec 22, 2025

0001213900-25-124530OWNERSHIP DOCUMENT

Sep 19, 2025

5.1 KB

4/A

Dec 22, 2025

0001213900-25-124529OWNERSHIP DOCUMENT

Sep 19, 2025

5.1 KB

4/A

Dec 22, 2025

0001213900-25-124528OWNERSHIP DOCUMENT

Sep 19, 2025

5.1 KB

SCHEDULE 13D/A

Dec 17, 2025

0001213900-25-122793

—

7.8 KB

8-K

Dec 10, 2025

0001213900-25-120197CURRENT REPORT

Dec 8, 2025

1.3 MB

424B5

Dec 10, 2025

0001213900-25-119760PROSPECTUS SUPPLEMENT

—

425.0 KB

25 filings shown

CITIUS ONCOLOGY, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(232 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/29/26	DEF 14C	DEFINITIVE INFORMATION STATEMENT	→
1/20/26	PRE 14C	PRELIMINARY INFORMATION STATEMENT	→
9/26/25	DEF 14A	DEFINITIVE PROXY STATEMENT	→
2/24/25	DEFA14C	DEFINITIVE ADDITIONAL MATERIALS	→
2/24/25	DEF 14C	DEFINITIVE INFORMATION STATEMENT	→
2/12/25	PRE 14C	PRELIMINARY INFORMATION STATEMENT	→
↓

Filed	Form	Description
12/22/25	4/A	OWNERSHIP DOCUMENT	→
12/22/25	4/A	OWNERSHIP DOCUMENT	→
12/22/25	4/A	OWNERSHIP DOCUMENT	→
12/22/25	4/A	OWNERSHIP DOCUMENT	→
12/22/25	4/A	OWNERSHIP DOCUMENT	→
12/22/25	4/A	OWNERSHIP DOCUMENT	→
↓

Filed	Form	Description
3/2/26	EFFECT	EFFECT	→
2/20/26	POS AM	POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/12/26	EFFECT	EFFECT	→
12/17/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
11/14/25	SCHEDULE 13G	SCHEDULE 13G	→
↓